Shenouda Maged's Form 4 filing
Relmada Therapeutics, Inc. (RLMD) · filed May 20, 2025
- Accession no.
- 0001213900-25-046087
- Filed
- May 20, 2025, 6:03 PM ET
- Trade date
- May 16-20, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $97.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shenouda MagedCIK 0001658369 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | Common Stock | PPurchaseAcquired | +50,000 | $0.442 | +$22,100 | 138,335 | Direct | |
| May 19, 2025 | Common Stock | PPurchaseAcquired | +90,000 | $0.4854 | +$43,686 | 228,335 | Direct | |
| May 20, 2025 | Common Stock | PPurchaseAcquired | +60,000 | $0.5237 | +$31,422 | 288,335 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.